Gastritis & Stomach Inflammation
Comprehensive integrative medicine approach for lasting healing and complete recovery
Understanding Gastritis & Stomach Inflammation
Gastritis is an inflammatory condition of the stomach lining (gastric mucosa) characterized by erosion, irritation, or microscopic damage to the protective mucosal barrier. It can occur suddenly (acute) or develop slowly over time (chronic). The condition involves disruption of the gastric mucosal barrier that normally protects stomach tissues from the corrosive effects of hydrochloric acid and pepsin. Common causes include H. pylori infection, prolonged use of NSAIDs, excessive alcohol consumption, autoimmune processes, and stress-related mucosal damage. Symptoms range from burning epigastric pain, nausea, and vomiting to asymptomatic cases that may only be discovered during endoscopic evaluation. Untreated gastritis can lead to peptic ulcers, gastric bleeding, atrophic changes, and increased risk of gastric adenocarcinoma.
Recognizing Gastritis & Stomach Inflammation
Common symptoms and warning signs to look for
Burning or gnawing pain in upper abdomen (epigastrium), often worse after eating
Feeling of fullness or bloating in upper abdomen, even after small meals
Nausea, sometimes with vomiting (may contain blood or appear coffee-ground)
Loss of appetite and early satiety
Unexplained weight loss
Burping or belching, often with sour or bitter taste
Dark stools (melena) indicating upper GI bleeding
What a Healthy System Looks Like
A healthy gastric mucosa forms a sophisticated multi-layered defense system protecting the stomach wall from autodigestion by gastric acid and pepsin. The mucosal barrier consists of: (1) Surface epithelium - a single layer of columnar cells that secrete mucus and bicarbonate, creating a pH gradient from highly acidic lumen (pH 1-2) to near-neutral epithelium (pH 7). (2) Mucus layer - a thick (0.5-1mm), gel-like secretion of mucins (mainly MUC5AC and MUC6) that forms a physical barrier and traps bicarbonate. (3) Tight junctions between epithelial cells preventing back-diffusion of hydrogen ions. (4) Rich blood supply delivering oxygen, nutrients, and bicarbonate while removing diffused acid. (5) Prostaglandins - local hormones that stimulate mucus and bicarbonate secretion, maintain blood flow, and promote epithelial repair. (6) Epithelial cell turnover - rapid regeneration (every 2-6 days) replacing damaged cells. In health, this system maintains gastric pH at 1-2 in the lumen while keeping the epithelium at pH ~7, allowing the stomach to produce the acid needed for digestion while protecting its own tissues.
How the Condition Develops
Understanding the biological mechanisms
Gastritis develops when the delicate balance between aggressive factors (acid, pepsin, H. pylori, NSAIDs, alcohol) and defensive mechanisms (mucus, bicarbonate, blood flow, prostaglandins) is disrupted. Key mechanisms include: (1) H. pylori colonization - bacteria penetrate the mucus layer using urease (converts urea to ammonia, neutralizing acid locally), triggering intense inflammation via CagA and VacA toxins, causing chronic active gastritis in 90-100% of infected individuals. (2) NSAID-induced damage - prostaglandin synthesis inhibition depletes protective mucus and bicarbonate, reduces mucosal blood flow, and direct topical irritation allows acid back-diffusion. (3) Chemical injury - alcohol, bile reflux, and certain medications directly damage the mucosal epithelium. (4) Autoimmune gastritis - autoantibodies against parietal cells and intrinsic factor cause chronic inflammation, hypochlorhydria, and pernicious anemia. (5) Stress-related mucosal damage - severe physiological stress (ICU patients, major surgery, burns) causes splanchnic hypoperfusion and increased acid production, leading to ischemic mucosal injury. (6) Atrophic transformation - chronic inflammation leads to loss of gastric glands, intestinal metaplasia, and increased cancer risk. (7) Epithelial barrier dysfunction - tight junction disruption allows increased permeability and back-diffusion of acid, perpetuating inflammation.
Key Laboratory Markers
Important values for diagnosis and monitoring
| Test | Normal Range | Optimal | Significance |
|---|---|---|---|
| Serum Gastrin | 10-100 pg/mL | 25-50 pg/mL | Elevated in atrophic gastritis, pernicious anemia, Zollinger-Ellison syndrome; suppressed with PPI use |
| Pepsinogen I | 70-200 ng/mL | 100-150 ng/mL | Low levels indicate gastric atrophy; marker of gastric mucosal status |
| Pepsinogen I/II Ratio | >3 | >5 | Ratio <3 suggests atrophic gastritis; used in gastric cancer screening |
| Gastric pH | 1-2 (fasting) | 1.5-2.5 | pH >3 suggests hypochlorhydria; pH >7 requires investigation for atrophic changes |
| Intrinsic Factor Antibodies | Negative | Negative | Positive in autoimmune gastritis/pernicious anemia; indicates autoimmune destruction |
| Parietal Cell Antibodies | Negative | Negative | Positive in autoimmune gastritis; present in 80-90% of pernicious anemia cases |
| Vitamin B12 | 200-900 pg/mL | 400-800 pg/mL | Low in autoimmune gastritis due to intrinsic factor deficiency; functional deficiency possible with normal total B12 |
| Iron Studies (Ferritin, TIBC) | Ferritin: 30-400 ng/mL; TIBC: 250-450 mcg/dL | Ferritin: 50-150 ng/mL; TIBC: 280-350 mcg/dL | Chronic H. pylori gastritis and atrophic gastritis impair iron absorption; low ferritin with high TIBC suggests iron deficiency |
| H. pylori Breath Test | Negative | Negative | Gold standard for H. pylori diagnosis; positive indicates active infection requiring treatment |
| Upper Endoscopy with Biopsy | Normal mucosa, no inflammation | Intact epithelium, minimal chronic inflammatory cells | Direct visualization; classifies gastritis type (erosive, atrophic, intestinal metaplasia); assesses H. pylori, dysplasia |
Root Causes We Address
The underlying factors contributing to your condition
{"cause":"H. pylori Infection","contribution":"Most common cause worldwide (50-70% of chronic gastritis); bacterial colonization triggers chronic active inflammation; responsible for 60-70% of peptic ulcers and 80% of gastric cancers","assessment":"Urea breath test, stool antigen, or biopsy during endoscopy; assess for virulence factors (CagA, VacA); evaluate for extraintestinal manifestations"}
{"cause":"NSAID and Aspirin Use","contribution":"Accounts for 30-40% of acute gastritis cases; chronic use causes 30-50% of peptic ulcers; risk increases with dose, duration, concurrent steroids/ anticoagulants","assessment":"Medication history including OTC NSAIDs; assess indication for use; consider PPI prophylaxis if NSAID use unavoidable"}
{"cause":"Excessive Alcohol Consumption","contribution":"Direct chemical injury to gastric mucosa; increases gastric acid secretion; impairs mucosal blood flow and repair mechanisms; dose-dependent relationship","assessment":"Alcohol use history (units/week); AUDIT questionnaire; assess for alcoholic liver disease; may require supervised reduction"}
{"cause":"Autoimmune Gastritis","contribution":"5-10% of chronic gastritis; autoantibodies against parietal cells (90%) and intrinsic factor (50%); leads to pernicious anemia; associated with other autoimmune conditions","assessment":"Parietal cell antibodies, intrinsic factor antibodies, vitamin B12, gastrin levels; autoimmune panel (thyroid, adrenal); gastric biopsy"}
{"cause":"Bile Reflux","contribution":"Post-surgical (gastrectomy, Roux-en-Y) or pyloric dysfunction; bile salts damage gastric mucosa; causes chemical gastropathy","assessment":"History of upper GI surgery; bile reflux symptom questionnaire; endoscopy shows bile staining; gastric aspirate analysis"}
{"cause":"Stress-Related Mucosal Disease","contribution":"Major physiological stress (ICU, burns, trauma, surgery); splanchnic hypoperfusion + increased acid = ischemic mucosal injury; occurs within 24-72 hours of stressor","assessment":"Identify stressor; risk assessment tools (APACHE II); ICU monitoring; prophylaxis for high-risk patients"}
{"cause":"Dietary Factors","contribution":"Certain foods may irritate damaged mucosa (spicy foods, acidic foods, caffeine); role in causation vs. symptom exacerbation varies","assessment":"Food diary; elimination diet trial; identify trigger foods; assess for food allergies/intolerances"}
Risks of Inaction
What happens if left untreated
{"complication":"Peptic Ulcer Disease","timeline":"Weeks to months of untreated chronic gastritis","impact":"30-50% of H. pylori-positive patients develop ulcers; risk increases with continued NSAID use; complications include bleeding (most common), perforation, and obstruction"}
{"complication":"Gastrointestinal Bleeding","timeline":"Can occur acutely in erosive gastritis or chronically","impact":"May present as hematemesis, melena, or occult bleeding causing anemia; accounts for 30% of upper GI bleeding; can be life-threatening requiring hospitalization and transfusion"}
{"complication":"Atrophic Gastritis and Intestinal Metaplasia","timeline":"Years of chronic inflammation","impact":"Loss of gastric glands and replacement with intestinal-type epithelium; permanent condition; requires surveillance; 2-6x increased risk of gastric adenocarcinoma"}
{"complication":"Gastric Adenocarcinoma","timeline":"10-30 years of chronic inflammation with metaplasia-dysplasia sequence","impact":"Fifth most common cancer worldwide; often presents late with weight loss, vomiting, anemia; 5-year survival <30% if advanced; intestinal type develops via Correa cascade"}
{"complication":"Pernicious Anemia","timeline":"5-10 years of untreated autoimmune gastritis","impact":"Megaloblastic anemia from B12 deficiency; neurological complications (paresthesias, ataxia, dementia) may be irreversible; increased cardiovascular risk from elevated homocysteine"}
{"complication":"Nutritional Deficiencies","timeline":"Progressive with chronic malabsorption","impact":"Iron deficiency (microcytic anemia), B12 deficiency (megaloblastic, neurological), calcium/magnesium deficiency (osteoporosis, muscle cramps); impacts energy, cognition, bone health"}
{"complication":"SIBO and Malabsorption","timeline":"Develops with chronic hypochlorhydria","impact":"Bacterial overgrowth causes bloating, diarrhea, further malabsorption; may worsen nutritional status; creates cycle of gut dysfunction"}
How We Diagnose
Comprehensive assessment methods we use
{"test":"Upper Endoscopy (EGD) with Biopsy","purpose":"Gold standard for gastritis diagnosis and classification","whatItShows":"Direct visualization of gastric mucosa; classifies gastritis type (erosive, atrophic, hemorrhagic); assesses intestinal metaplasia; detects H. pylori (biopsy); rules out ulcers, cancer"}
{"test":"H. pylori Testing","purpose":"Identify primary cause of gastritis","whatItShows":"Urea breath test (active infection), stool antigen, or endoscopic biopsy; determines need for eradication therapy; test-of-cure after treatment"}
{"test":"Serum Biomarkers (Pepsinogen, Gastrin)","purpose":"Assess gastric mucosal status and detect atrophy","whatItShows":"Low pepsinogen I and low ratio indicate atrophic gastritis; elevated gastrin suggests autoimmune or atrophic changes; used in gastric cancer screening"}
{"test":"Autoimmune Gastritis Workup","purpose":"Identify autoimmune cause","whatItShows":"Parietal cell antibodies, intrinsic factor antibodies; vitamin B12 levels; thyroid function tests (associated autoimmune thyroiditis)"}
{"test":"Gastric Acid Analysis","purpose":"Assess acid secretion capacity","whatItShows":"Basal acid output, maximal acid output; helps distinguish hypersecretory states (Zollinger-Ellison) from hypochlorhydria/achlorhydria"}
{"test":"Complete Blood Count","purpose":"Screen for complications","whatItShows":"Anemia (microcytic from iron deficiency, macrocytic from B12 deficiency); leukopenia in severe autoimmune gastritis"}
{"test":"Iron Studies and B12","purpose":"Assess nutritional status","whatItShows":"Ferritin, TIBC, iron, B12 levels; identify deficiencies requiring supplementation"}
{"test":"Gastric Biopsy Pathology","purpose":"Histological classification","whatItShows":"Chronic inflammation (lymphocytes, plasma cells), activity (neutrophils), atrophy, intestinal metaplasia, dysplasia; updated Sydney classification"}
Our Treatment Approach
How we help you overcome Gastritis & Stomach Inflammation
Phase 1: Acute Symptom Control and Etiology Treatment (Weeks 1-4)
{"phase":"Phase 1: Acute Symptom Control and Etiology Treatment (Weeks 1-4)","focus":"Rapid symptom relief and treat underlying cause","interventions":"Identify and treat root cause: H. pylori eradication (quadruple therapy: PPI + bismuth + tetracycline + metronidazole for 14 days). Discontinue NSAIDs if possible; if not, add PPI prophylaxis. Acid suppression with PPI or H2 blocker for 4-8 weeks. Avoid irritants: alcohol, smoking, spicy foods, caffeine. Eat small, frequent meals. Antacids for immediate symptom relief. Protect gastric mucosa with sucralfate. Baseline endoscopy with biopsies if alarm symptoms or persistent symptoms >4 weeks.\n"}
Phase 2: Mucosal Healing and Nutritional Support (Weeks 4-12)
{"phase":"Phase 2: Mucosal Healing and Nutritional Support (Weeks 4-12)","focus":"Restore mucosal integrity and address deficiencies","interventions":"Continue acid suppression as needed; consider H2 blocker if PPI side effects. Test for and treat nutritional deficiencies: B12 injections (if autoimmune), iron supplementation, vitamin D. Probiotics to restore gut microbiome (particularly after antibiotics). Consider zinc carnosine for mucosal healing. Gastric mucosal protectants: sucralfate, misoprostol. Evaluate autoimmune gastritis with serial B12 and iron studies. Repeat endoscopy only if symptoms persist or alarm features develop.\n"}
Phase 3: Long-Term Management and Surveillance (Months 3-12)
{"phase":"Phase 3: Long-Term Management and Surveillance (Months 3-12)","focus":"Maintain remission and prevent complications","interventions":"Taper acid suppression to lowest effective dose or on-demand. For atrophic gastritis: surveillance endoscopy every 1-3 years based on severity and risk. Monitor and treat nutritional deficiencies long-term. For autoimmune gastritis: annual B12,iron, thyroid monitoring. Address H. pylori - confirm eradication 4 weeks after treatment. Lifestyle modification: stress management, dietary modifications, alcohol reduction, smoking cessation. Consider maintenance therapy with mucosal protectants for high-risk patients.\n"}
Phase 4: Maintenance and Complication Prevention (Year 1+)
{"phase":"Phase 4: Maintenance and Complication Prevention (Year 1+)","focus":"Sustain healing, monitor for complications, optimize quality of life","interventions":"Ongoing surveillance for atrophic gastritis and intestinal metaplasia (per updated guidelines based on risk stratification). Continued nutritional support as needed. Maintain healthy lifestyle. Regular screening for associated conditions (thyroid, diabetes). For high-risk patients: consider chemoprevention with PPIs (some data for reduced gastric cancer risk post-H. pylori eradication). Dental checkups every 6 months (reflux can affect teeth). Patient education on alarm symptoms requiring immediate attention.\n"}
Diet & Lifestyle
Recommendations for optimal recovery
Lifestyle Modifications
Weight management: obesity increases intra-abdominal pressure and reflux, Stress management: chronic stress worsens gastritis; meditation, yoga, therapy, Adequate sleep: 7-8 hours; prop head of bed if reflux present, Avoid tight-fitting clothing: reduces abdominal pressure, No NSAIDs or limit to minimum: use acetaminophen instead when possible, Limit caffeine: stimulates acid production, Regular gentle exercise: promotes digestion and reduces stress, Stay upright after meals: 30-60 minutes
Recovery Timeline
What to expect on your healing journey
Phase 1 (Weeks 1-4): Identify and treat root cause (H. pylori eradication, discontinue NSAIDs). Begin acid suppression therapy. Symptom relief typically within 1-2 weeks. Patient education on triggers and lifestyle. Baseline labs and endoscopy if indicated. Most patients see significant improvement by week 4.
Phase 2 (Weeks 4-12): Continue mucosal healing. Test for and treat nutritional deficiencies. Monitor for medication side effects. Address autoimmune cause if present. Many patients achieve substantial symptom control by week 8.
Phase 3 (Months 3-12): Step down acid suppression for responders. Surveillance endoscopy for atrophic gastritis. Long-term nutritional monitoring. Lifestyle maintenance. Most patients experience major improvement or resolution of symptoms.
Phase 4 (Year 1+): Maintenance therapy as needed. Ongoing surveillance for atrophic gastritis and metaplasia. Monitor for complications. With proper treatment, 70-80% of patients achieve good symptom control. H. pylori eradication provides long-term cure for bacterial gastritis.
Note: Individual timelines vary. Autoimmune gastritis requires lifelong monitoring and supplementation. Severe atrophic gastritis with intestinal metaplasia needs ongoing surveillance for cancer prevention.
How We Measure Success
Outcomes that matter
Complete resolution of epigastric pain and burning
Normalization of appetite and ability to eat without discomfort
Resolution of nausea and vomiting
Stable weight (no further loss, return to healthy weight)
Successful H. pylori eradication (negative test of cure)
Healing of gastric mucosa on follow-up endoscopy (if performed)
Normalization of pepsinogen and gastrin levels (in atrophic gastritis)
Correction of nutritional deficiencies (B12, iron, ferritin)
Improved quality of life scores
No progression of atrophic changes or intestinal metaplasia
Frequently Asked Questions
Common questions from patients
What is the difference between gastritis and gastroenteritis?
Gastritis is inflammation of the stomach lining (gastric mucosa), typically chronic and related to H. pylori, NSAIDs, or autoimmune processes. Gastroenteritis is inflammation of the stomach and intestines, usually acute and caused by infections (viral, bacterial, parasitic). Gastroenteritis presents with acute vomiting, diarrhea, and cramping, usually resolving within days. Gastritis is chronic, causing persistent epigastric pain, burning, and nausea. They are different conditions with different causes, treatments, and prognoses.
Can gastritis be cured completely?
The outlook depends on the cause: H. pylori gastritis can be cured with successful eradication therapy - this eliminates the bacteria and allows the mucosa to heal. NSAID-induced gastritis improves when NSAIDs are stopped and acid suppression is provided. Autoimmune gastritis cannot be cured but can be managed effectively with B12 supplementation and monitoring. Most patients achieve significant symptom control and mucosal healing with proper treatment. The key is identifying and addressing the underlying cause. Without treatment, chronic gastritis can progress to more serious conditions like ulcers, atrophy, or cancer.
Is gastritis caused by stress?
Stress can exacerbate gastritis and cause acute stress-related mucosal damage in critically ill patients, but stress alone is rarely the sole cause of chronic gastritis. The main causes are H. pylori infection (50-70% of cases), NSAID use, autoimmune processes, and alcohol. However, stress can worsen symptoms, increase acid production, delay healing, and create a cycle of symptom exacerbation. Managing stress through meditation, yoga, therapy, and adequate sleep is an important part of treatment. Severe physiological stress (ICU, major surgery, burns) can cause acute hemorrhagic gastritis requiring urgent treatment.
What foods should I avoid with gastritis?
Avoid foods that irritate the stomach lining or stimulate acid: spicy foods, acidic foods (citrus, tomatoes), chocolate, caffeine (coffee, tea, soda), peppermint, fatty/fried foods, alcohol, and carbonated beverages. Everyone's triggers differ, so keeping a food diary helps identify personal triggers. During acute flares, stick to bland, easily digestible foods ( bananas, rice, applesauce, toast, lean proteins). Once symptoms improve, gradually reintroduce foods. Eating small, frequent meals rather than large meals reduces stomach irritation.
How long does it take for gastritis to heal?
Acute gastritis from NSAID use or alcohol typically improves within days to weeks after removing the trigger and starting acid suppression. H. pylori gastritis improves within 4-8 weeks after completing eradication therapy. Chronic gastritis may take months to years to fully heal, and some changes like atrophy or metaplasia may be permanent. The timeline depends on: cause, severity, adherence to treatment, lifestyle factors, and individual healing capacity. Following treatment protocols and avoiding triggers accelerates healing.
When should I see a doctor for gastritis symptoms?
See a doctor if: symptoms last more than 2 weeks, over-the-counter medications don't help, you have severe pain, symptoms worsen, or you experience alarm symptoms. Seek immediate care for: vomiting blood or material that looks like coffee grounds, black/tarry stools, difficulty swallowing, unexplained weight loss, persistent vomiting, severe weakness (suggesting anemia), or symptoms after taking NSAIDs or aspirin. These could indicate ulcers, bleeding, or more serious conditions requiring urgent evaluation.
Medical References
- 1.Lanas A, Chan FKL. Peptic Ulcer Disease. Lancet. 2017;390(10094):613-624. PMID: 28242110 - Comprehensive review of peptic ulcer and gastritis pathophysiology.
- 2.Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6-30. PMID: 27707777 - Evidence-based guidelines for H. pylori management.
- 3.Rugge M, Sugano K, Caruso R, et al. Gastritis: New Clinical Classification. Nat Rev Gastroenterol Hepatol. 2023;20(4):231-246. PMID: 36750652 - Modern classification and management of gastritis.
- 4.Matsuzaki J, Suzuki H. Autoimmune Gastritis: Clinical Features and Pathogenesis. Intern Med. 2019;58(14):2001-2009. PMID: 31028050 - Pathophysiology and management of autoimmune gastritis.
- 5.Correa P, Piazuelo MB. The Gastric Precancerous Cascade. J Dig Dis. 2012;13(1):2-9. PMID: 22257430 - Understanding the progression from gastritis to gastric cancer.
Ready to Start Your Healing Journey?
Our integrative medicine experts are ready to help you overcome Gastritis & Stomach Inflammation.